Prevail Partners

Coologics operates as a clinical stage medical device company offers a drug-free solution for vaginal yeast infections.

Triple Hair focuses on developing effective solutions for thinning hair and hair loss, specifically targeting conditions like alopecia. The company has created a triple combination therapy that enhances hair regrowth by utilizing synergistic effects to promote hair growth in men. This innovative approach not only aims to prevent hair loss but also seeks to improve hair thickness and pigmentation, addressing the concerns of individuals experiencing hair loss.

Operator of a cancer immunotherapy company intended to develop medicines to treat primary, recurrent and metastatic cancers. The company uses several different technologies and approaches utilizing viral vectors and affinity agents that can be conjugated to deliver biologicals, enabling doctors to utilize new and advanced treatments to cure patients even in advanced stages of cancer.

HemoGenyx LLC is a biopharmaceutical company based in Brooklyn, New York, focused on developing innovative treatments for blood diseases, including leukemia, lymphoma, and bone marrow failure. Incorporated in 2013, the company specializes in utilizing adult hemogenic endothelial cells, which are capable of generating cancer-free hematopoietic stem cells for transplantation. This approach aims to enhance the effectiveness of bone marrow transplants while potentially eliminating the necessity for donor matches. HemoGenyx operates as a subsidiary of Hemogenyx Pharmaceuticals Ltd.

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company focused on immuno-oncology and the development of innovative therapies for cancer management. The company’s lead candidate, Bria-IMT, is a targeted cell-based immunotherapy derived from a breast cancer cell line, currently undergoing a Phase I/IIa clinical trial in combination with immune checkpoint inhibitors for advanced breast cancer. BriaCell has achieved positive proof-of-concept for Bria-IMT in this patient population. Additionally, the company is developing Bria-OTS, an off-the-shelf personalized immunotherapy aimed at advanced breast cancer, as well as BriaDx, a diagnostic test. BriaCell Therapeutics is headquartered in West Vancouver, Canada, and collaborates with the National Cancer Institute to advance its research initiatives.

PolyPhotonix is a bio-photonic research and development company focused on the design, development, and manufacture of non-invasive photonic-based medical devices. The company specializes in creating innovative home care treatment products that utilize light therapy to address macular eye diseases, particularly diabetic retinopathy. By collaborating with designers and key customers, PolyPhotonix supports the entire design process up to manufacturing at the National Printable Electronics Centre, aiming to pioneer the early adoption of organic light technology in medical applications.